key: cord-0980536-quhebpmh
authors: Abrich, Victor; Olshansky, Brian
title: Torsades de Pointes Following Vaccination for COVID-19
date: 2022-04-09
journal: HeartRhythm Case Rep
DOI: 10.1016/j.hrcr.2022.04.003
sha: b2237fc266465d035d45908378dc5ec2cfac100d
doc_id: 980536
cord_uid: quhebpmh

nan

Disclosures: Neither author report any conflicts associated with this submission. Dr. Olshansky 12 was chairman of the DMC of the REDUCE-IT Trial, was co-coordinator of the GLORIA AF Trial, 13 was a consultant for Sanofi Aventis and a speaker for Lundbeck. None of these disclosures are 14 related to this submission. Torsades de Pointes is a polymorphic ventricular tachycardia that can cause syncope and 21 lead to sudden cardiac death. This arrhythmia is initiated by early after depolarizations in the 22 setting of prolonged ventricular repolarization, manifesting as QT prolongation on the 12-lead 23 electrocardiogram. 1 Common risk factors include QT prolonging medications, electrolyte 24 disturbances, bradycardia, and certain inherited genetic mutations. 2 We report a case of 25 Figure 2A . However, the QT interval at this precordial location may not 94 necessarily appear prolonged owing to regional differences in the QT interval between leads on 95 a 12-lead ECG. 3 The presence of premature ventricular complexes on the presenting ECG in 96 Figure 1 also supports this arrhythmia mechanism following her initial syncopal episode prior to 97 loop recorder implantation. The presence of myocarditis, which has been linked to the COVID-98 19 vaccine by Pfizer-BioNTech 4 , may have also increased the risk of arrhythmogenesis. 99

Unfortunately, detailed cardiac imaging with PET or MRI were not performed as they were 100 unavailable at the treating facility. 101

Following resuscitation from the cardiac arrest, our patient's presenting electrolytes 102 demonstrated mild hypocalcemia, however serum potassium and magnesium levels were 103 within normal limits; it was not until 3 hours following her initial presentation that she became 104 profoundly hypokalemic as would be expected from a prolonged cardiac arrest. The mechanism 105 is thought to be from a transmembrane shift in potassium from the vascular space into cells 106 caused by either a neurohumoral response to the cardiac arrest itself, catecholamine therapy 107 during the arrest, or due to rapid correction of metabolic acidosis from the administration of 108 bicarbonate and mechanical ventilation. 5,6 109

The observed QT prolongation on subsequent ECGs could have been attributed to 110 amiodarone and hypokalemia. The larger differences in the QT interval on different leads in 111 Figure 3B (e.g. lead II compared to V2) suggest an elevated QT dispersion which is also 112 associated with an increased risk of ventricular arrhythmias. 3 The presence of an inherited 113 channelopathy such as Long QT Syndrome was considered. She had no history of syncope as a 114 child and there was no significant family history. Genetic testing was not performed. New onset 115

Torsades de Pointes in congenital Long QT Syndrome is rare starting at this age. 116

Given that her cardiac arrest occurred within 12 hours after receiving her COVID-19 117 vaccination, the vaccine itself should be considered as a potential contributor in a susceptible 118 individual. However, it is also important to note that she did not report any significant side 119 effects after receiving the first two doses of the same COVID-19 vaccine. Her single syncopal 120 episode one month after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine 121 may or may not have been related to the vaccine. It is possible that a non-sustained ventricular 122 arrhythmia triggered by myocarditis could have caused her syncopal episode one month after 123 the second vaccination, especially given the finding of a mildly reduced ejection fraction on her 124 initial echocardiogram. 125

Vaccination against COVID-19 has been shown to reduce the incidence of severe illness, 126 hospitalization, and death due to the virus and is associated with a low risk of adverse events. 7 127 associated with QT prolongation. 9 This finding has been attributed to excessive inflammation 131 modulating potassium and calcium channels that can lead to ventricular arrhythmias including 132 

Clinical and genetic determinants of torsade de pointes risk

Will QT dispersion play a role in clinical decision-making?

COVID-19 Vaccine and Myocarditis

Hypokalemia after resuscitation from out-of-hospital 177 ventricular fibrillation

Frequency of hypokalemia after 179 successfully resuscitated out-of-hospital cardiac arrest compared with that in transmural 180 acute myocardial infarction

Effectiveness of COVID-19 vaccines and their challenges 182 (Review)

COVID-19 Infection and Corrected QT Interval Prolongation-187